Xcout Intel
ADmit Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to ADmit Therapeutics among biotechnology companies — ranked by similarity to what ADmit Therapeutics actually does, not by market-cap band.
Subscribe to see ADmit Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ADmit Therapeutics
ADmit Therapeutics S.L. is a biotechnology company founded in 2017 in Barcelona, Spain, that emerged from the Bellvitge Biomedical Research Institute. The company specializes in developing early diagnostic tools and tests for neurodegenerative diseases.
ADmit Therapeutics at a glance
ADmit Therapeutics is a biotechnology company headquartered in Spain. It has raised at least $5.9M across the 2 funding rounds on record. Its most recent funding round, Grant, raised $497,652 in May 2026. Xcout tracks 15 named people at ADmit Therapeutics, including Marta Barrachina (CEO Co-Founder Board Member).
ADmit Therapeutics leadership
- Marta BarrachinaCEO Co-Founder Board Member
- Ferran PratChairman of the Board
- Marta BarrachinaCEO Co-Founder Board Member
- Jordi GascónCo-Founder and Member of the Medical Advisory Board
- Ramón ReñéCo-Founder and Member of the Medical Advisory Board
- Alfred Fu Kong LuiLaboratory Director
9 more named people on record for ADmit Therapeutics, with roles, board committees and tenure — see the full roster →
ADmit Therapeutics funding rounds
At least $5.9M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $497,652 | 7 named | |
| — | $5.4M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 ADmit Therapeutics competitors
Ranked by semantic similarity — how close each company is to ADmit Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Reveal Genomics, S.L. is a biotechnology company founded in 2020 and headquartered in Barcelona, Spain. The company develops innovative genomic tools to improve breast cancer treatment and personalized medicine.
Similar biotechnology company
Veravas Inc. develops diagnostic technology and testing solutions, including its proprietary VeraBIND platform, designed to reduce laboratory test interference and detect hard-to-find biomarkers. The company primarily serves clinicians, researchers, and patients by providing tools and assays focused on the early detection of complex conditions such as Alzheimer's disease and other dementias.
Biotech
Saccade is a medical and diagnostic laboratory startup located in San Francisco, California. The company is developing early screening technology and diagnostic tests for Alzheimer's disease.
Healthcare & Life Sciences
Cognision is a biotechnology research company headquartered in Louisville, Kentucky (with primary offices also noted in Boston, Massachusetts). The firm develops advanced neurological assessment tools and diagnostic technologies.
Diagnostics & Genetic Testing
Athena Diagnostics provides specialized diagnostic and genetic testing services focusing on neurological diseases, neuromuscular disorders, and developmental disorders such as Alzheimer's disease and muscular dystrophy. The company serves patients and healthcare providers by offering test catalogs, sample collection kits, requisition resources, and billing support.
Similar biotechnology company
Biohope is a commercial-stage biotechnology and R&D company based in Madrid, Spain, dedicated to developing precision medicine in vitro diagnostic tools for chronic medical conditions.
Diagnostics
Inbiomotion is a biotechnology research company based in Barcelona, Spain, that develops a single-gene-based diagnostic test providing objective predictive and prognostic data.
Similar biotechnology company
SunBird Bio, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing blood-based diagnostic tests for neurological and oncological diseases.
Similar biotechnology company
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Diagnostics
i2Dx, Inc. is a US-based company founded in 2012 that develops a multimodal, cloud-based diagnostic platform. The platform is designed for the assessment and diagnosis of neurological disorders using quantitative digital assessments.
Biotech
Universal Diagnostics is a biotechnology and digital health company focused on advanced diagnostic solutions. The company maintains its main headquarters and operational offices in Seville, Spain, alongside corporate listings.
Healthcare & Biotechnology
BRAINBox Solutions, Inc. is a medical diagnostics company headquartered in Richmond, Virginia, focused on developing innovative tools and technologies to help clinicians diagnose traumatic brain injuries (TBI).
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ADmit Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ADmit Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →